https://la-newswire.com/wp-content/uploads/2021/11/22831.png
1929
1535
Jane
Jane
https://la-newswire.com/wp-content/uploads/2021/09/Jane-96x96.jpg
AXON presented results from its Phase II Clinical Study for AADvac1, vaccine against Alzheimer’s presented at Eurotau2021AXON demonstrated that vaccination-induced antibodies can stop the interaction and spreading of pathological tau species and protect the brain…